Contemporary treatment options for prostate cancer are considered to have comparable efficacy. Therefore other differences such as treatment related toxicities, impact on quality of life, convenience, treatment time, and cost become important considerations in influencing treatment choice.
The goal of brachytherapy is to achieve high precision, targeted radiotherapy utilising advanced computerised treatment planning and image guided delivery systems to achieve tailored ablative tumour dose to the prostate whilst sparing surrounding organs at risk to minimise potential toxicities. This article is protected by copyright. All rights reserved.BJU international 2015 Aug 11 [Epub ahead of print]
Michael Wt Chao, Peter Grimm, John Yaxley, Raj Jagavkar, Michael Ng, Nathan Lawrentschuk
Radiation Oncology Victoria, Ringwood East, Victoria, Australia , Prostate Cancer Center of Seattle, Seattle, WA, USA , The Wesley Hospital, Brisbane, Queensland, Australia , St Vincent's Hospital, Darlinghurst, NSW, Australia , Radiation Oncology Victoria, Epping, Victoria, Australia , Department of Surgery and Olivia Newton John Cancer Research Institute, Austin Hospital and Peter MacCallum Cancer Centre, Department of Surgical Oncology, Victoria, Australia